A Biolab &Co é reconhecida pelo forte foco em Pesquisa e Inovação, que impulsiona o desenvolvimento de novos produtos para compor o portfólio da companhia. Contamos com três Centros de Pesquisa, Desenvolvimento e Inovação (PD&I). Dois desses centros estão empenhados no desenvolvimento de medicamentos e suplementos alimentares para uso humano e veterinário, dois deles instalados em território brasileiro e o terceiro estrategicamente localizado no Canadá, com o objetivo de fortalecer e acelerar nosso alcance internacional. Já o quarto centro de PD&I, também situado no Brasil, se especializa exclusivamente no estudo de novas moléculas e na pesquisa fundamental para inovações radicais.
These centers add new products to Biolab's portfolio and thus expand the choice of medicines for the community and health professionals. They also focus on improving the products already in the group's portfolio. Investing in Research, Development and Innovation results in the launch of safer and more effective medicines.
The demands for product development arise from unmet medical needs, market trends and partnerships with private institutions, research institutes and universities.
Our investments make it possible to use advanced technologies at every stage, from development to production. They also train our professionals and align our procedures with both national and international regulatory requirements.
We highlight projects carried out in partnership, such as the drug Vonau Flash®, developed jointly with the Faculty of Pharmaceutical Sciences of the University of São Paulo (FCF-USP), which has brought benefits to the population, the company and the university.
In addition, we are making progress on various projects at different stages of pre-clinical and clinical study, linked to incremental and disruptive (radical) innovations.
It concerns modifications and updates made to an existing product.
The aim is to create a new and innovative solution.